Component
Neural-activity-evoked cerebral blood flow
Neural-activity-evoked cerebral blood flow. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Soluble PIP2 administration restored Kir2.1-dependent neurovascular responses in the studied mouse model.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/inositol-research/33875602.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "139eeba386e63329898f8e36ebe93ad741eed904819bbebe7fc2b1808130a19d", "start_char": 0, "end_char": 1108, "text_sha256": "139eeba386e63329898f8e36ebe93ad741eed904819bbebe7fc2b1808130a19d"}
- experimental_model
- Genetic small-vessel disease mouse model and lipid rescue
- exposure
- PIP2 depletion and soluble PIP2 administration
- limitations
- Mouse disease model; not evidence that oral inositol treats human cerebrovascular disease.
- nutrient_topic
- Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
- organism
- Mus musculus
- plain_language
- Replacing the deficient lipid signal restored a blood-flow response in these mice.
- primary_references
- [ino-p33875602] PIP2 corrects cerebral blood flow deficits in small vessel disease by rescuing capillary Kir2.1 activity. (2021). https://pubmed.ncbi.nlm.nih.gov/33875602/ DOI: 10.1073/pnas.2025998118
- tissue_or_cell_type
- Brain capillary endothelium and cerebral circulation
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 1029–1040
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Genetic small-vessel disease mouse model and lipid rescue · source_derived_draft · unverified_draft
### ino-kir-flow-rescue Soluble PIP2 administration restored Kir2.1-dependent neurovascular responses in the studied mouse model. Condition category: machinery_impairment nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: Replacing the deficient lipid signal restored a blood-flow response in these mice. organism: Mus musculus tissue_or_cell_type: Brain capillary endothelium and cerebral circulation experimental_model: Genetic small-vessel disease mouse model and lipid rescue limitations: Mouse disease model; not evidence that oral inositol treats human cerebrovascular disease. exposure: PIP2 depletion and soluble PIP2 administration evidence_span: {"source_cache": "artifacts/inositol-research/33875602.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "139eeba386e63329898f8e36ebe93ad741eed904819bbebe7fc2b1808130a19d", "start_char": 0, "end_char": 1108, "text_sha256": "139eeba386e63329898f8e36ebe93ad741eed904819bbebe7fc2b1808130a19d"} [ino-p33875602] PIP2 corrects cerebral blood flow deficits in small vessel disease by rescuing capillary Kir2.1 activity. (2021). https://pubmed.ncbi.nlm.nih.gov/33875602/ DOI: 10.1073/pnas.2025998118
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.